Concepedia

A Model-Independent Method to Determine Restricted Mean Survival Time in the Analysis of Survival Curves

Andrea Messori, Vera Damuzzo, Laura Agnoletto, Luca Leonardi, Marco Chiumente, Daniele Mengato

SN Comprehensive Clinical Medicine · 2019 · 22 citations · 5 references

DOI

Concepts

References

5

Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma

Tony Mok, Yi‐Long Wu, Sumitra Thongprasert et al. · New England Journal of Medicine · 2009 · 8.2K citations · Full text

, , +13

The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt

Patrick Royston, Mahesh Parmar · Statistics in Medicine · 2011 · 579 citations

, , +17

Kinetic evaluation of four Factor VIII concentrates by model‐independent methods

Marzia Matucci, Andrea Messori, Giancarlo Donati-Cori et al. · Scandinavian Journal of Haematology · 1985 · 77 citations

, , +12

An approach to trial design and analysis in the era of non-proportional hazards of the treatment effect

Patrick Royston, Mahesh Parmar · Trials · 2014 · 40 citations · Full text

, , +17

Visualizing Length of Survival in Time-to-Event Studies: A Complement to Kaplan Meier Plots

Patrick Royston, Mahesh Parmar, Doug Altman · JNCI Journal of the National Cancer Institute · 2008 · 39 citations · Full text

, , +16